drugset / Trial / NCT06723691

Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

NCT06723691

Phase 1 Completed 57 enrolled Fujian Shengdi Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the influence of HRS9531 injection on gastric emptying and pharmacokinetics of metformin, atorvastatin, warfarin, and digoxin in healthy subjects.

Timeline

Start
2024-12-18
Primary completion
2025-06-09
Completion
2025-06-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Digoxin Other / unclassified
Subject HRS9531 Unknown
Subject Metformin Small molecule
Subject Warfarin Small molecule
Background Acetaminophen Small molecule